T regulatory cells and HIV infection

AIDS Reviews

Volumn 9, Issue 1, 2007, Pages 54-60

  Sempere, José M ^a   Soriano, Vincent ^b   Benito, José Miguel ^b  

^a UNIVERSITY OF ALICANTE   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

HIV; Immune activation; T cells responses; Treg cells

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN EXPRESSION; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; INFECTION CONTROL; LYMPHOCYTE FUNCTION; OPPORTUNISTIC INFECTION; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

HIV; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; T-LYMPHOCYTES, REGULATORY;

EID: 34248382192     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Itoh M, Takahashi T, Sakaguchi N, et al. Thymus and autoimmunity production of CD25+CD4+ naturally anergic and suppressive T-cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999;162:5317-22.
2. Chai J, Bartok J, Chandler P, et al. Anergic T-cells act as suppressor cells in vitro and in vivo. Eur J Immunol 1999;29:686-92.
3. Head S, Powrie F. CD4+ regulatory T-cells. Curr Opin Immunol 2001;13:644-9.
4. Shevach E. Certified Professionals. CD4+CD25+ suppressor T-cells. J Exp Med 2001;193:41-5.
5. Maloy J, Powrie F. Regulatory T-cells in the control of immune pathology. Nature Immunol 2001;2:816-22.
6. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.
7. Stephens L, Mottet C, Mason D, Powrie F. Human C04+CD25+ thymocytes and peripheral T-cells have immunosuppressive activity in vitro. Eur J Immunol 2001;31:1247-54.
8. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk A. Identification and functional characterization of human CD4+CD25+ T-cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193:1285-94.
9. Levings M, Sangregorio R, Roncarolo M. Human CD4+CD25+ Treg cells suppress naive and memory T-cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193:1295-302.
10. Bach F. Regulatory T cells under scrutiny. Nat Rev Immunol 2003; 3:189-98.
11. Salomon B, Lenschow D, Rhee L, et al. B7/CD28 co-stimulation is essential for the homeostasis of CD4+CD25+ immunoregulatory T-cells that control autoimmune diabetes. Immunity 2000;12:431-40.
12. Akbar A, Taams L, Salmon M, Vurmanovic-Stejic M. The peripheral generation of CD4+CD25+ regulatory T-cells. Immunology 2003;109:319-25.
13. Thornton A, Piccirillo CA, Shevach E. Activation requirements for the induction of CD4+CD25+ T-cell suppressor function. Eur J Immunol 2004;34:366-76.
14. Von Boehmer H. Mechanisms of suppression by suppressor T-cells. Nat Immunol 2005;6:338-44.
15. Ronchetti S, Zollo D, Bruscoli S, et al. GITR, a member ot the TNF receptor superfamily, is co-stimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 2004;34:613-22.
16. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
17. Kunisayu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S. Naturally anergic and suppressive CD25+CD4+ T-cells as a functionally and phenotypically distinct immunoregulatory T-cell subpopulation. Int Immunol 2000;12:1145-55.
18. Putnam A, Vendrame F, Dolts F, Gottlieb P. CD4+CD25high regulatory T-cells in human autoimmune diabetes. J Autoimmun 2005; 24:55-62.
19. Baecher-Allan C, Brown J, Freeman G, Hafler D. CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245-53.
20. Fontenot J, Rasmussen J, Williams L, Dooley J, Farr A, Rudensky A. Regulatory T-call lineage specification by the forkhead transcription factor Foxp3. Immunity 2005;22:329-41.
21. Ziegler S. FOXP3: of mice and men. Annu Rev Immunol 2006; 24:209-26.
22. Liu W, Putnam A, Xu-yu Z, et al. CD127 expression inversely correlates with Foxp3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006;203:1701-11.
23. Baecher-Allan C, Wolf E, Hafler D. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T-cells. Clin Immunol 2005;115:10-18.
24. Levings M, Roncarolo M. Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T-cells. Curr Top Microbiol Immunol 2005;293:303-26.
25. Annacher O, Pimenta-Araujo H, Burlen-Defranoux D, Barbosa T, Cumano A, Bandeira A. CD25+CD4+ T-cells regulate the expansion of peripheral CD4 T-cells through the production of IL-10. J Immunol 2001;166:3008-18.
26. Weiner H. Oral tolerance: immune mechanisms and the generation of Th3-type TGFα-sacreting regulatory cells. Microbes Infect 2001; 3:947-54.
27. Belghith M, Bluestone J, Barriot S, Megret J, Bach J, Chatenoud L. IGFβ-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9:1202-8.
28. Miedema F, Chantal-Petit A, Terpstra F, et al. Immunologic abnormalities in HIV-infected asymptomatic homosexual men. J Clin Invest 1988;82:1908-14.
29. Sousa A, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino H. CD4 T-cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002;169:3400-8.
30. Hazenberg M, Otto S, van Banthem M, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003;17:1881-7.
31. McHugh R, Whitters M, Piccirillo D, et al. CD4+CD25+ immunoregulatory T-cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-23.
32. Kataoka H, Takahashi K, Takase S, et al. CD25+CD4+ regulatory T-cells exert in vitro suppressive activity independent of CTLA-4. Int Immunol 2005;17:421-7.
33. Fontenot J, Gavin M, Rudensky A. Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol 2003;4:330-6.
34. Sereti I, Imamichi H, Natarajan V, et al. In vivo expansion of CD4+CD45RO-CD25+ I-cells expressing Foxp3 in IL2-treatad HIV-infecfed patients. J Clin Invest 2005;115:1839-47.
35. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carboneil C, Levy Y. HIV-driven expansion of CD4+CD25+ regulatory T-cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004;104:3249-56.
36. Aandahl E, Michaelsson J, Moretto W, Hecht F, Nixon D. Human CD4+CD25+ regulatory cells control T-cell responses to HIV and cytomegalovirus antigens. J Virol 2004;78:2454-9.
37. Tsunemi S, Iwasaki I, Imado T, et al. Relationship of CD4+CD25+ regulatory T-cells to immune status in HIV-infected patients. AIDS 2005;19:879-86.
38. Nilsson J, Boasso A, Andrea Velilla P, et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006;108:3808-17.
39. Oswald-Ritcher K, Grill S, Shariat N, et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004;2:955-66.
40. Eggena M, Barugahare B, Jones N, et al. Depletion of regulatory T-cells in HIV infection is associated with immune activation. J Immunol 2005;174:4407-14.
41. Kinter A, Hennesay M, Bell A, et al. CD25+CD4+ regulatory T-cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T-cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004;200:331-43.
42. Epple H, Loddenkemper C, Kunkel D, et al. Mucosal but not peripheral Foxp3+ regulatory T-cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006; 108:3072-8.
43. Montes M, Lewis D, Sanchez C, et al. Foxp3+ regulatory T-cells in antiretroviral-naive HIV patients. AIDS 2006;20:1669-70.
44. Anderson J, Boasso A, Nilsson J, et al. The prevalence of regulatory T-cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005;174:3143-7.
45. Chougnet C, Velilla P, Nilsson J, Boasso A, Andersson J, Shearer G. Interactions between regulatory T-cells and HIV: a complex balancing act. 14th CROI. Los Angeles, February 25-28 2007 [abstract 159].